Vital children's cancer drug being underdosed
(Medical Xpress)—A study has found that many patients receiving a potentially life-saving drug for the childhood cancer neuroblastoma are potentially being under-dosed.
Every year in the UK approximately 100 children aged between 0-15 are diagnosed with neuroblastoma and currently only half of those will survive. The drug, 13-cis-retinoic acid, has been used in high doses to treat children with the disease for the last ten years. It plays a key role in stopping cancer returning after tumours are treated by surgery, chemotherapy and radiotherapy.
In the paper, published today in the journal Clinical Cancer Research, the team at Newcastle University describe how, when they looked at a large number of cases of neuroblastoma over a three year period, they found that in three quarters of cases the patients were achieving drug exposures which may not be beneficial.
Although there are few side effects with the treatment, the main challenge to giving the drug is that it only comes in capsule form. As most children with neuroblastoma are too young to swallow the capsules, they have to be opened up and the contents either put down the child's feeding tube or mixed with food such as yoghurt or ice cream. This means it's very hard to control exact doses, as some medicine can be left in the capsule or not transferred efficiently.
It is believed this under-dosing could have a significant impact on the child's recovery, although the exact impact has yet to be assessed.
As a result of the study, patients are now being prescribed extra medication.
Lead researcher on the project, Dr Gareth Veal, senior lecturer at the Northern Institute of Cancer Research at Newcastle University, said: "This could have serious repercussions for the outcome of the child in terms of long-term survival. We have now started increasing dose levels so that patients receive a personalised dose that leads to drug exposures that we hope will be beneficial. We will be following up these patients to see if it makes a difference to survival rates for a disease which is incredibly challenging to treat successfully."
"It's too early to say if these changes will improve long-term outcome for this type of cancer but I would anticipate that increasing the dose of this drug could lead to an increased chance of survival for many children."
Dr Veal and colleagues studied 70 patients from The Newcastle upon Tyne Hospitals NHS Foundation Trust receiving 13-cis-retinoic acid from hospitals around the UK and found that particularly in babies, where doses prescribed are often lower than those received by older children, levels of 13-cis-retinoic acid in the blood were frequently much lower than those thought to be effective. As a result of this the researchers recommended 25-50% dose increases in patients who experienced low drug exposures, in order for all patients to achieve the correct blood levels.
The study has led to changes in the way that this important drug is dosed in the majority of neuroblastoma patients, with babies now given the same dose as older children and patients who are not able to swallow the 13-cis-retinoic acid capsules also prescribed an increased dose level.
More information: Gareth, J. et al., Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma, Clinical Cancer Research. January 17, 2013. clincancerres.aacr… ent/19/2/469
Journal reference: Clinical Cancer Research
Provided by Newcastle University
- New chemo regimen helps children with neuroblastoma Jun 06, 2011 | not rated yet | 0
- Scientists develop new strategy to overcome drug-resistant childhood cancer Jul 11, 2012 | not rated yet | 0
- Biomarker associated with poor outcome in aggressive childhood cancer Apr 06, 2009 | not rated yet | 0
- How the drug isotretinoin zaps acne Mar 03, 2008 | not rated yet | 0
- Cancer Research UK launches trial of new drug to treat acute childhood leukaemia Jan 27, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be villous adenoma in colon, if there are no villi there
17 hours ago As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
- More from Physics Forums - Medical Sciences
More news stories
(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.
Cancer 7 hours ago | not rated yet | 0
National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the ...
Cancer 7 hours ago | not rated yet | 0
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...
Cancer 11 hours ago | not rated yet | 0 |
When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...
Cancer 11 hours ago | not rated yet | 0 |
Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.
Cancer 15 hours ago | not rated yet | 0
Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...
50 minutes ago | not rated yet | 0
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
11 hours ago | 4.9 / 5 (7) | 0 |
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
11 hours ago | 4 / 5 (1) | 0 |
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
8 hours ago | 5 / 5 (2) | 2 |
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
8 hours ago | 4 / 5 (2) | 0 |
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
9 hours ago | not rated yet | 0 |